📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
Legislation, Industry, and the Future of Psilocybin for PTSD
The FDA acceptance of Compass Pathway’s Investigational New Drug Application for their COMP360 compound as a possible therapy for PTSD introduces a new area of possible therapies using psilocybin. The post Legislati...
Neuroscientist Uses VR to Study Why Psychedelics Make Us Trip
Virtual reality offers a new lens on the science behind the psychedelic experience. [...] Read More... The post Neuroscientist Uses VR to Study Why Psychedelics Make Us Trip appeared first on DoubleBlind Mag.
Can Psychedelics Help Mend Broken and Ailing Brains?
Stroke, traumatic brain injury, and neurodegenerative diseases are leading, interconnected causes of global disability and economic burden with limited effective treatments. Sam Gandy highlights the potential of psych...
Patient Safety After a Death: What Transparency Can and Cannot Do
A Tragedy at an Ibogaine Clinic — and the Policy Failure Behind It A patient death in any care setting is a tragedy. In this case, it involves ibogaine, a medically complex intervention that sits outside regulated med...
The Psychedelic News Feed: January 26 – Febraury 1, 2026
Your one-stop digest for the latest coverage of psychedelics business, policy, research and beyond, for the week commencing January 26, 2026.
Psychedelic narcissism: 5 Questions for psychotherapy researcher Henrik Jungaberle
Jungaberle discusses how the drugs famous for ego-death can also reinforce the ego.
MAPS and Columbia University Partner on First-of-its-Kind Study of MDMA-Assisted Couples Therapy
February 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announces a formal research partnership with Columbia University to study how practitioners are facilitating MDMA-assisted couples th...
Q3 2025: Oregon Psilocybin Services Update
Oregon Psilocybin Services (OPS) has now published its third dataset for 2025, with updates summarised in our Oregon Psilocybin Services Tracker. Here, we share a summary of the main takeaways for Pα+ subscribers.
Is Psilocybin’s Next Frontier Metabolic Health?
PLUS misinformation on psychedelic policy and medicine worker arrests. [...] Read More... The post Is Psilocybin’s Next Frontier Metabolic Health? appeared first on DoubleBlind Mag.
Notes From Mexico
This Week’s Sunday Insider: An unsentimental account of my days in Mexico.
Beyond the Trip: How Fungi Are Engineering Our Future
The ancient, subterranean networks of fungi underpin life on Earth and are now emerging as a powerful foundation for future sustainable biotechnologies. The post Beyond the Trip: How Fungi Are Engineering Our Future a...
2026 Tickets ON SALE NOW!
Earlybird tickets to our 2026 event are on sale now!
New Theories and Findings From The Frontier of Ibogaine Research
After publishing a new study investigating synthetic analogs for iboga molecules, scientist and co-founder of Gilgamesh Pharmaceuticals, Dalibor Sames, decided to take the compound he has described as an intelligent ...
Ibogaine consortium gains steam with new bills in MS and OK; Federal psychedelics efforts remain stagnant
Plus: Distinguishing psychological “support” from therapy and Oregon Psilocybin Services closes loophole allowing after-hours events
We Are Looking for an E-Learning & Alumni Experience Manager (Junior)
ICEERS Academy | Type: Remote (or hybrid in Barcelona) | Languages: Spanish and English About ICEERS Academy ICEERS Academy is the training arm of ICEERS, dedicated to promoting more ethical and safer practices in wor...